Cite
LC-MS Fingerprinting Development for Standardized Precipitate from Agastache mexicana , Which Induces Antihypertensive Effect through NO Production and Calcium Channel Blockade †.
MLA
Cruz-Torres, Karla Catalina, et al. “LC-MS Fingerprinting Development for Standardized Precipitate from Agastache Mexicana , Which Induces Antihypertensive Effect through NO Production and Calcium Channel Blockade †.” Pharmaceutics, vol. 15, no. 9, Sept. 2023, p. 2346. EBSCOhost, https://doi.org/10.3390/pharmaceutics15092346.
APA
Cruz-Torres, K. C., Estrada-Soto, S., Arias-Durán, L., Navarrete-Vázquez, G., Almanza-Pérez, J. C., Mora-Ramiro, B., Perea-Arango, I., Hernández-Núñez, E., Villalobos-Molina, R., Carmona-Castro, G., Medina-Díaz, I.-M., & Ávila-Villarreal, G. (2023). LC-MS Fingerprinting Development for Standardized Precipitate from Agastache mexicana , Which Induces Antihypertensive Effect through NO Production and Calcium Channel Blockade †. Pharmaceutics, 15(9), 2346. https://doi.org/10.3390/pharmaceutics15092346
Chicago
Cruz-Torres, Karla Catalina, Samuel Estrada-Soto, Luis Arias-Durán, Gabriel Navarrete-Vázquez, Julio César Almanza-Pérez, Beatriz Mora-Ramiro, Irene Perea-Arango, et al. 2023. “LC-MS Fingerprinting Development for Standardized Precipitate from Agastache Mexicana , Which Induces Antihypertensive Effect through NO Production and Calcium Channel Blockade †.” Pharmaceutics 15 (9): 2346. doi:10.3390/pharmaceutics15092346.